Clinical Trials Directory

Trials / Unknown

UnknownNCT03394547

Pulsed Electromagnetic Field Treatment for Painful Periods

PUlsed electroMagnetic Field Treatment for Painful Periods: A Randomised Control Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Birmingham Women's NHS Foundation Trust · Other Government
Sex
Female
Age
16 Years
Healthy volunteers
Accepted

Summary

A single-centre, randomised controlled, double blind study comparing use of the Allay pulsed shortwave therapy treatment versus a placebo device or no treatment for management of primary dysmenorrhea.

Detailed description

Women participating in the trial will be randomly allocated to any of the three arms of the study. * Treatment for 2 menstrual cycles using the PSWT Allay device (BioElectronics Corp, Frederick USA) * Treatment for 2 menstrual cycles using a placebo device * No treatment. If they are allocated to a device both the participant and the clinician will be blinded at to weather they are using the active device or the placebo. Primary Outcome measures are: * A reduction in dysmenorrhea as measured by the highest pain score on a 10cm visual analogue scale. * A reduction in average pain score on a 10cm visual analogue scale * A reduction in use of analgesia as recorded in a pain diary * Improvement in quality of life as measured through a validated quality of life assessment tool (SF-36 questionnaire) \- Improvement in menstrual symptoms as recorded through a validated questionnaire (the Modified Menorrhagia Multi-attribute Scale (MMAS)). * Device acceptability as measured on a 5-point Likert scale ranging from "unacceptable" to "totally acceptable". * Impact upon associated cyclical symptoms as recorded in a patient symptom diary

Conditions

Interventions

TypeNameDescription
DEVICEAllaypulsed shortwave therapy treatment for painful periods
DEVICEPlaceboA placebo device is given which is identical to the Allay device but emits no pulsed shortwave therapy.

Timeline

Start date
2017-11-03
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2018-01-09
Last updated
2018-06-13

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03394547. Inclusion in this directory is not an endorsement.